|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 164-173, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
W Flameng, GJ Van der Vusse, R De Meyere, M Borgers, P Sergeant, E Vander Meersch, J Geboers and R Suy
Myocardial preservation was assessed in 72 patients undergoing extensive
myocardial revascularization. The patients were allocated at random to
three surgical techniques: Group 1, intermittent aortic cross- clamping at
32 degrees C; Group 2, intermittent aortic cross-clamping at 25 degrees C;
and Group 3, St. Thomas' Hospital cardioplegia. As intraoperative markers
of ischemic damage, adenosine triphosphate, creatine phosphate, and
glycogen contents were determined in transmural left ventricular biopsy
specimens taken at the beginning and at the end of cardiopulmonary bypass.
Ultrastructure was studied in a similar pair of biopsy specimens. Release
of myocardium-specific creatine kinase isoenzyme was determined
intraoperatively and postoperatively. Functional recovery was assessed
before and after weaning from cardiopulmonary bypass. The incidence of low
cardiac output, myocardial infarction, and rhythm disturbances was compared
between groups. Finally, actuarial survival and event-free curves were
studied after 18 months' follow-up. The results show a better preservation
of high- energy phosphates, glycogen, and ultrastructure in the
cardioplegia group as compared to the two cross-clamp groups. However,
severe myocardial damage was never observed. Release of MB creatine kinase
isoenzyme was the same in all three groups. Functional recovery of the
hearts immediately after cessation of cardiopulmonary bypass was better in
the cardioplegia group, but the incidence of rhythm disturbances
(atrioventricular conduction problems) was higher in the cardioplegia group
than in the other two groups (p less than 0.05). Clinical outcome in terms
of incidence of perioperative infarction, survival, and event- free
follow-up was not different between groups. It is concluded that both
techniques (aortic cross-clamping at 32 degrees C or 25 degrees C and St.
Thomas' Hospital cardioplegia) offer good myocardial protection in
extensive aorta-coronary bypass operations. St. Thomas' cardioplegia,
however, in contrast to intermittent aortic cross- clamping, prevents the
onset of ischemia-induced deterioration of cardiac metabolism, i.e.,
destruction of the adenine nucleotide pool.
ARTICLES
Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study
This article has been cited by other articles:
![]() |
U. Sunderdiek, P. Feindt, and E. Gams Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 393 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Wong, S. Vendargon, C. G. Lim, P. S. Wong, S. Vendargon, and C. G. Lim Coronary Artery Bypass Surgery Without Cardioplegia: Early Results Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sawa, K. Taniguchi, K. Kadoba, M. Nishimura, H. Ichikawa, A. Amemiya, T. Kuratani, and H. Matsuda Leukocyte Depletion Attenuates Reperfusion Injury in Patients With Left Ventricular Hypertrophy Circulation, May 1, 1996; 93(9): 1640 - 1646. [Abstract] [Full Text] |
||||
![]() |
Y. Sawa, H. Matsuda, Y. Shimazaki, M. Kaneko, M. Nishimura, A. Amemiya, K. Sakai, and S. Nakano Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1125 - 1131. [Abstract] [Full Text] |
||||
![]() |
Y. Sawa, J. Schaper, M. Roth, K. Nagasawa, G. Ballagi, N. Bleese, and W. Schaper Platelet-activating factor plays an important role in reperfusion injury in myocardiumEfficacy of platelet-activating factor receptor antagonist (CV-3988) as compared with leukocyte-depleted reperfusion J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 953 - 959. [Abstract] [Full Text] |
||||
![]() |
G. Noera, C. Massini, and G. Baggio In vitro plasma nifedipine concentration during heart-lung machine function Perfusion, October 1, 1987; 2(4): 277 - 281. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |